Clinical Trial

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

Name: To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL — clinical trial record (NCT07143929)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: S101P

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated August 27, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Summary

To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed PTCL.

Trial Details

NCT Number	NCT07143929
Lead Sponsor	Peking University People's Hospital
Conditions	CD7 Positive R/R PTCL
Enrollment	18 participants
Start Date	2025-08-18
Primary Completion	2026-07-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-27